Trends in State-Level Pharmacy-Based Naloxone Dispensing Rates, 2012-2019.
Trends in State-Level Pharmacy-Based Naloxone Dispensing Rates, 2012-2019.
复制标题
DOI:
10.1016/j.amepre.2021.05.042
复制
发表时间:
2021-12
影响因子:
5.5
通讯作者:
Arifkhanova, Aziza
中科院分区:
文献类型:
--
作者:
Guy Jr, Gery P.;Khushalani, Jaya S.;Jackson, Hannah;Sims, Rebekah St. Clair;Arifkhanova, Aziza
Improving access to naloxone is an important public health strategy in the U.S. This study examines the state-level trends in naloxone dispensing from 2012 to 2019 for all 50 states and the District of Columbia. Data from IQVIA Xponent were used to examine the trends and geographic inequality in annual naloxone dispensing rates and the number of naloxone prescriptions dispensed per high-dose opioid prescription from 2012 to 2019 and from 2016 to 2019 to correspond with the Centers for Disease Control and Prevention Guideline for Prescribing Opioids for Chronic Pain release. Annual percentage change was estimated using linear regression. Analyses were conducted in 2020. Naloxone dispensing rates and the number of naloxone prescriptions per 100 high-dose opioid prescriptions increased from 2012 to 2019 across all states and the District of Columbia. Average state-level naloxone dispensing rates increased from 0.55 per 100,000 population in 2012 to 45.60 in 2016 and 292.31 in 2019. Similarly, the average number of naloxone prescriptions per 100 high-dose opioid prescriptions increased from 0.002 in 2012 to 0.24 in 2016 and 3.04 in 2019. Across both measures of naloxone dispensing, the geographic inequality gap increased during the study period. In 2019, the number of naloxone prescriptions dispensed per 100 high-dose opioid prescriptions ranged from 1.04 to 16.64 across states. Despite increases in naloxone dispensing across all states, dispensing rates remain low, with substantial variation and increasing disparities over time at the state level. This information may be helpful in efforts to improve naloxone access and in designing state-specific intervention programs.
登录
查看更多内容
影响因子:
2.2
作者:
Rees, Daniel I.;Sabia, Joseph J.;Latshaw, Joshua
通讯作者:
Latshaw, Joshua
DOI:
10.1016/j.japh.2019.11.024
发表时间:
2020-05-01
影响因子:
2.1
作者:
Eldridge, Lori Ann;Agley, Jon;Meyerson, Beth E.
通讯作者:
Meyerson, Beth E.
影响因子:
4.2
作者:
Haffajee, Rebecca L.;Cherney, Samantha;Smart, Rosanna
通讯作者:
Smart, Rosanna
影响因子:
5.7
作者:
Binswanger, Ingrid A.;Koester, Stephen;Glanz, Jason M.
通讯作者:
Glanz, Jason M.
DOI:
10.1001/jama.2016.1464
发表时间:
2016-04-19
期刊:
JAMA
影响因子:
--
作者:
Dowell D;Haegerich TM;Chou R
通讯作者:
Chou R